Clinical Trial: The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Glabellar Frown Lines
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Single Group, Open, Extension Study of Phase III Clinical Trial to Compare the Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
Brief Summary:
This clinical trial is an extended clinical trial for test subjects who participated in the phase 3 clinical trial of PT_BTA_P3_21 (clinical trial plan number) and completed follow-up observation up to 16 weeks after administration of clinical trial drugs, and evaluates the effectiveness and safety of repeated administration of protoxin in those with moderate or severe brow wrinkles.
Read more